Forbes August 8, 2024
A big California health insurer that grabbed headlines a year ago for its effort to “rip up the playbook on drug pricing,” may launch with Mark Cuban’s Cost Plus Drugs in a different role than originally billed.
The role of Mark Cuban Cost Plus Drug Company has changed a year after Blue Shield of California a year ago announced the prescription management model that also includes Amazon, a pharmacy benefit venture owned by Blue Cross and Blue Shield plans called Prime Therapeutics, and Abarca Health, a pharmacy benefit and services firm.
A year ago, Blue Shield of California said Mark Cuban Cost Plus Drug Company will “establish a simple, transparent, and more affordable pricing model, reducing surprise drug costs at...